.png)
Founded in 1995, PenRad provides informatics for Breast, Lung, Diagnostic Radiology, and Genetics, optimizing productivity and risk management initiatives. PenRad delivers on promises made regarding revenue enhancement, functionality, multi-vendor interoperability, analytics, and delivery of patient-centric results.
PenRad invests within the healthcare community, driving benefits for the future of diagnostic technology, techniques, analysis, and structured data exchange. We provide leadership and software in standardization initiatives in HL7 FHIR workgroups: Clinical Interoperability Modeling Initiative and the Cancer-Interoperability project supported by the ONC, FDA, CDC, NCI, NIH, RSNA.
Accomplish More with PenRad Automated Solutions
PenRad’s High Risk Breast Clinic streamlines and optimizes women’s imaging center resources, all to the benefit of the patient, families, and the clinic. Incorporates technology for genetic testing eligibility, and Tyrer Cuzick breast cancer risk assessment value.
PenRad and PenTrac are full featured, automated breast clinic information systems focused on reducing costs, enhancing care and optimizing revenue.
PenConnect provides timely emailed results and reminders (minimizes mailing and overhead expense).
PenXpress allows your patients to remotely update their medical history and risk factors, and other information with PenForms, streamlining check-in.
PenLung for automating Lung LDCT and Non-LCSR data collection and tracking. Includes an extensive COVID dataset, Lung-RADS and CO-RADS.
PenAlert for automating tracking of all radiology exam types for findings and patient result notification.
PenGen allows facilities to collect and manage patients’ risk assessments and genetic testing eligibility. System calculates real-time Tyrer Cuzick values, and Genetic testing eligibility based on multiple models, for patients and their relatives.